Rocket Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -37.2% | -37.2% | -34.0% |
| FY2022 | -45.3% | -45.3% | -40.2% |
| FY2023 | -49.9% | -49.9% | -43.4% |
| FY2024 | -55.9% | -55.9% | -49.0% |
| FY2025 | -80.5% | -80.5% | -67.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -37.2% | -37.2% | -34.0% |
| FY2022 | -45.3% | -45.3% | -40.2% |
| FY2023 | -49.9% | -49.9% | -43.4% |
| FY2024 | -55.9% | -55.9% | -49.0% |
| FY2025 | -80.5% | -80.5% | -67.5% |